Chemplast Sanmar Ltd Q1 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Published 4 Aug 2026 | Chemicals & Petrochemicals | Market Cap: ₹2.9K Cr

Specialty business capacity built during tough quarters is expected to act as a springboard for future growth. Specialty business capacity built during the tough PVC market phase is expected to act as a springboard for future growth.

From Chemplast Sanmar Ltd's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.

Price

₹177

Market Cap

₹2.9K Cr

How does Chemplast Sanmar Ltd rank in Chemicals & Petrochemicals?

Compare Chemplast Sanmar Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Chemplast Sanmar Ltd — Quarterly revenue & net profit

Revenue Net Profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹1.3K Cr, net profit ₹-45 Cr.

Full financials →

📊 Revenue & Sales Performance

- Specialty business capacity built during tough quarters is expected to act as a springboard for future growth. - Custom Manufactured Chemicals Division (CMCD) shows a strong and healthy pipeline with active customer engagement, expected to accelerate from next year. - Agro-chemical sector is recovering, with an increase in inquiries and expected ramp-up of sales volumes in CMCD. - Demand for Paste PVC in India is expected to grow at 7-8% annually. - Suspension PVC demand outlook remains positive with 4% growth in domestic demand this quarter. - Government infrastructure projects are expected to drive pipe demand, supporting PVC sales growth. - Renewable power initiatives may lead to cost savings, indirectly benefiting profitability and margins. - Expansion projects like MPB Phase 3 and the upcoming R32 project are progressing, underpinning future volume increases. Overall, Chemplast Sanmar is optimistic about steady growth driven by capacity expansion, recovering end markets, and improving trade remedy actions.

📈 Profitability & Margins

→Specialty business capacity built during the tough PVC market phase is expected to act as a springboard for future growth.
→Custom Manufactured Chemicals Division (CMCD) shows strong pipeline; growth expected with new project phases (MPB 3 Phase 3 and MPB 4) completing by FY27.
→Ag-chem sector recovery anticipated to accelerate inquiries and orders starting next year, supporting volume growth.
→Renewable power projects covering 35-40% of power needs could save INR 50-60 crores, improving margins.
→Anti-dumping duties (ADD) on Suspension and Paste PVC expected to improve spreads and reduce pricing pressure.
→Market rationalization in China and possible PVC plant closures in Europe may stabilize global supply, benefiting margins.
→Company targets medium to long-term growth primarily through CMCD investments beyond FY27.
→Overall, management remains optimistic about margin improvement and volume growth driven by product mix and regulatory actions.

🏗️ Capital Expenditure Plans

→The multipurpose block Phase 3 of Custom Manufacturing is ongoing and progressing as per approved capex limits with completion expected by Q3 FY '26.
→Civil works for the next production block, MPB 4, have also commenced with a similar timeline.
→The R32 refrigerant gas project has received environmental clearance; however, the exact sizing and total capex are yet to be decided. Current approvals are enabling in nature.
→Final decisions on R32 project sizing and siting will be taken soon, keeping in mind quota approvals to ensure capital deployment aligns with entitlements.
→Future capital deployment preference strongly favors the Custom Manufacturing and Custom Synthesis & Manufacturing Development (CSMD) business, with investments triggered upon achieving ~60% visibility in existing blocks.

💰 Fundraising & Capital Structure

→The exact capex for the upcoming R32 project is yet to be finalized, including its sizing.
→Currently, only enabling approval for the project capex has been taken; actual capex will be decided once the sizing is finalized.
→No specific details are provided regarding the funding mix between internal accruals and debt for the R32 project as of the call.
→The only ongoing project mentioned with approved capex is the multipurpose block Phase 3 of Custom Manufacturing, progressing as per plan.
→There is no explicit mention of new fundraising through debt or equity in the transcript.
→Future capital deployment preference is indicated towards the Custom Manufactured Chemicals Division, with investments being triggered based on 60% visibility of orders.
→Overall, any capital expenditure is to be carefully aligned with quota approvals and project sizing decisions before committing funds.

📋 Order Book & Pipeline

→The Custom Manufactured Chemicals Division (CMCD) dispatches are currently on track and as per schedule.
→The multipurpose block Phase 3 expansion is progressing well, with completion expected in the next 2 to 3 months.
→Construction for MPB 4 civil works is also nearing completion within the same timeline.
→The pipeline of inquiries and customer engagement remains healthy and strong.
→The company maintains very active engagement with customers, including multiple visits, audits, and inquiries over the past year.
→Future investments and expansions in CMCD will be triggered once visibility for 60% of the current block is secured.
→The focus remains on broadening the customer base, especially with global agro-chem majors diversifying supply chains.
→Overall, the orderbook and pending orders are robust and support ongoing and future capacity expansions.

Key Metrics

What Chemplast Sanmar's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Archean Chemical (Q1 FY26)
Q1 FY26 standalone EBITDA grew 13% YoY to INR 958 million with 33% margin; consolidated net profit stood at INR 401 million. Key concall takeaways from Archean…
PCBL Chemical Ltd (Q1 FY26)
Plant closures in Europe/North America may open export opportunities, boosting international sales beyond the current 41% mix. Key concall takeaways from PCBL…
Rain Industries Ltd (Q1 FY26)
Carbon segment capacity utilization is around 68%, with efforts to increase utilization underway. Key concall takeaways from Rain Industries's Q1 FY26 earnings…
Styrenix Perfor. (Q1 FY26)
Thailand plant utilization is at 50-55% with potential to increase revenue by 70-80% by ramping up capacity and improving product mix. Key concall takeaways…

Compare:vs Solar Industries India Ltd vs Pidilite Inds.vs SRF

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Chemplast Sanmar Ltd Q1 FY26 results?

What is Chemplast Sanmar Ltd share price analysis?

Chemplast Sanmar Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹2,911 Cr. Investors should review the full earnings analysis for detailed insights.

Is Chemplast Sanmar Ltd planning capital expenditure?

The multipurpose block Phase 3 of Custom Manufacturing is ongoing and progressing as per approved capex limits with completion expected by Q3 FY '26. - Civil works for the next production block, MPB 4, have also commenced with a similar timeline. - The R32 refrigerant gas project has received environmental clearance; however, the exact sizing and total capex are yet to be decided.

Keep Chemplast Sanmar Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.